The presence of certain indels can have prognostic value, indicating how aggressive a cancer might be or how it will respond to treatment. For example, indels in the BRCA1 and BRCA2 genes are associated with hereditary breast and ovarian cancers and can guide decisions about preventive measures and targeted therapies.
